iiinova — where your digital self keeps evolving

From Testing to Targeted Treatment (FT3) @ft3community.bsky.social · 01/10/2026

Familiar faces, new connections and wonderful energy! Our FT3 Town Hall brought updates from Mexico, Taiwan and Nigeria, plus lively conversations on personalised healthcare. Thank you to everyone who joined and made it such a pleasure. See you at the next one!

000

From Testing to Targeted Treatment (FT3) @ft3community.bsky.social · 30/09/2026

From our online Townhall to Madrid on 21–22 October, the FT3 community will come together to share experiences, work through common challenges and shape solutions for better patient access. Share → Learn → Collaborate → Act Let's turn shared learning into practical ideas to take home.

000

From Testing to Targeted Treatment (FT3) @ft3community.bsky.social · 29/09/2026

Precision medicine cannot be advanced by one stakeholder alone. FT3 brings patients, diagnostics, industry, healthcare professionals, researchers & implementation leaders into a neutral space to connect, identify shared barriers & drive action. What could make collaboration more actionable?

100

From Testing to Targeted Treatment (FT3) @ft3community.bsky.social · 22/09/2026

Strong evidence doesn’t guarantee patient access. Funding, policy, infrastructure, reimbursement and gaps between testing and treatment can all stand in the way. Hear from FT3 Board members on what’s holding precision medicine back & what needs to change.

100

From Testing to Targeted Treatment (FT3) @ft3community.bsky.social · 17/09/2026

Today’s the day! We’re looking forward to bringing the FT3 community together for a great conversation on precision medicine advocacy. Bring your questions. Bring your perspective. See you today at 15:00 CEST! 👉 precisionmedicine.synapseconnect.org/events/ft3-t...

precisionmedicine.synapseconnect.org

FT3 Town Hall Meeting September 2026

The FT3 Town Hall quarterly series offers an excellent opportunity to explore ongoing projects, stay updated with the latest from our dedicated project groups, and actively engage/get involved in our…

000

From Testing to Targeted Treatment (FT3) @ft3community.bsky.social · 16/09/2026

Just one more day to go! We’re looking forward to the FT3 Town Hall tomorrow. A great opportunity to hear new perspectives, exchange ideas & learn from others working to advance precision medicine. precisionmedicine.synapseconnect.org/events/ft3-t...

000

From Testing to Targeted Treatment (FT3) @ft3community.bsky.social · 15/09/2026

Just 2 days to go for the FT3 Town Hall. Register now if you have not done it yet. 📅 17 September 2026 ⏰ 15:00–16:00 👉 Register now: precisionmedicine.synapseconnect.org/events/ft3-t...

000

From Testing to Targeted Treatment (FT3) @ft3community.bsky.social · 15/09/2026

Why do we show up for precision medicine? For Catalina, it became deeply personal. For Espen, it’s about hearing perspectives beyond industry. For Lee-Anne, it’s about staying connected to the realities of care. Different perspectives. One shared purpose. #PrecisionMedicine #FT3Voices

000

From Testing to Targeted Treatment (FT3) @ft3community.bsky.social · 14/09/2026

3 days to go! Patient advocates, researchers, healthcare professionals, industry experts & decision-makers are joining the FT3 Town Hall to explore what it takes to move precision medicine from evidence to action. Have you registered? precisionmedicine.synapseconnect.org/events/ft3-t...

000

From Testing to Targeted Treatment (FT3) @ft3community.bsky.social · 11/09/2026

What works in one health system may not work in another. But we can learn from each other. Join the FT3 Town Hall on 17 Sept to compare approaches, share challenges and turn global learning into local action. 15:00–16:00 precisionmedicine.synapseconnect.org/events/ft3-t...

000

From Testing to Targeted Treatment (FT3) @ft3community.bsky.social · 09/09/2026

Precision medicine is advancing fast. But innovation alone won’t determine its impact. The FT3 Board sees five realities shaping what comes next — from lived experience and access to neutrality, local implementation and patient outcomes. Which one matters most in your health system or region?

100

From Testing to Targeted Treatment (FT3) @ft3community.bsky.social · 27/08/2026

What makes a compelling case for precision medicine? We’ll discuss the Casebook of Value Drivers in HTA & Value Assessment and more at the FT3 Town Hall on September 17. Join us: tinyurl.com/yaatjsun

000

From Testing to Targeted Treatment (FT3) @ft3community.bsky.social · 20/08/2026

What happens after the evidence is generated? At FT3’s September Town Hall, we’ll share learnings from ISPOR Global, PEOF and HTAi and explore how evidence can translate into local impact. 📅 17 Sept, 15:00–16:00 precisionmedicine.synapseconnect.org/events/ft3-t...

000

From Testing to Targeted Treatment (FT3) @ft3community.bsky.social · 12/08/2026

Our next FT3 Town Hall is happening on 17 September! Join in for updates on ongoing projects, new advocacy tools & practical resources designed to help make precision medicine accepted by decision-makers. precisionmedicine.synapseconnect.org/events/ft3-t...

000

From Testing to Targeted Treatment (FT3) @ft3community.bsky.social · 31/07/2026

Right information, at the right time, can lead to better decisions. FT3’s co-created Patient Information Needs Map helps advocates identify gaps and plan education across four stages of care. Explore and adapt the tool: www.fromtestingtotargetedtreatments.org/the-patient-...

000

From Testing to Targeted Treatment (FT3) @ft3community.bsky.social · 30/07/2026

150+ stakeholders. 10+ Local & global partners. 10 priority actions. In Mexico, FT3 and FUTEJE turned barriers to precision medicine access into a coordinated path forward, demonstrating how local leadership and practical tools can drive system-level change.

010

From Testing to Targeted Treatment (FT3) @ft3community.bsky.social · 29/07/2026

The ADAPT Care study is complete. The findings show that structured precision medicine education helps strengthen clinician-patient communication, improve understanding of biomarker testing & support more informed shared decision-making. Read the study: tinyurl.com/sk9rjsk6

000

From Testing to Targeted Treatment (FT3) @ft3community.bsky.social · 23/06/2026

What happens after diagnosis can have a lasting impact on patient engagement, treatment uptake & outcomes. Join us on 25 June to explore where support systems are falling short and what can be done to close the gap. patientengagement.synapseconnect.org/events/peof-...

000

From Testing to Targeted Treatment (FT3) @ft3community.bsky.social · 19/06/2026

You explain the diagnosis. But what happens after that? Join us on 25 June to explore how you as a specialist can better support patients in understanding, navigating, and acting on their care post diagnosis. Register for the PEOF+RARE session tinyurl.com/4vpyvfw4

000

From Testing to Targeted Treatment (FT3) @ft3community.bsky.social · 15/06/2026

Received a rare disease diagnosis? Supporting someone who has? Join us on 25 June to discuss what comes next - from understanding your condition and preparing for consultations to navigating care decisions with confidence. patientengagement.synapseconnect.org/events/peof-...

000

From Testing to Targeted Treatment (FT3) @ft3community.bsky.social · 10/06/2026

A patient advocate, clinician, and industry leader. Different perspectives. One goal: improving outcomes in rare diseases. Join the session, "From Unknown to Known – Empowering Patients in the Care Journey," June 25 (13:30 CET) as we explore patient empowerment after diagnosis. l1nq.com/2r9kra6

000

From Testing to Targeted Treatment (FT3) @ft3community.bsky.social · 04/06/2026

Healthcare innovation creates impact only when it reaches patients. Join FT3 at #HTAi2026 for an interactive workshop on how HTA can help close the innovation-implementation gap. 07 June | Istanbul, Türkiye Register now: htai.eventsair.com/htai-2026-is...

000

From Testing to Targeted Treatment (FT3) @ft3community.bsky.social · 29/05/2026

1,600+ people. 1,490+ organizations. One connected ecosystem. Synapse connects patient groups, researchers, organizations, initiatives, resources, and events into one living global network, enabling coordination across healthcare ecosystems. precisionmedicine.synapseconnect.org

020

From Testing to Targeted Treatment (FT3) @ft3community.bsky.social · 18/05/2026

The Precision Medicine Q&A helps patients ask the right questions at medical appointments, from diagnosis through relapse. Designed with patient organisations, it’s adaptable for different diseases and countries. www.fromtestingtotargetedtreatments.org/adaptable-ed...

000

From Testing to Targeted Treatment (FT3) @ft3community.bsky.social · 12/05/2026

Join the next FT3 Town Hall exploring the Precision in Practice training pilot and how multidisciplinary, people-centered training can drive real-world implementation across healthcare systems. 13 May 2026 | 16:30–17:30 CET Register: precisionmedicine.synapseconnect.org/events/ft3-t...

000

From Testing to Targeted Treatment (FT3) @ft3community.bsky.social · 11/05/2026

HTA looks different depending on where you sit. On 12 May, Catherine Koola Fischer, Eric Liu, and Alan Balch discuss what meaningful patient involvement in HTA looks like across different systems and perspectives. Register: eu1.hubs.ly/H0tzz850

000

From Testing to Targeted Treatment (FT3) @ft3community.bsky.social · 07/05/2026

Patient involvement in HTA isn’t new, but its impact is still underexplored, especially for innovative technologies where lived experience matters most. Join the ACCESS Series on 12 May to see how different systems are closing this gap in practice. 1:30–3:00 PM CEST eu1.hubs.ly/H0tzz850

000

From Testing to Targeted Treatment (FT3) @ft3community.bsky.social · 05/05/2026

What’s next for 2026? The shift is underway: Frameworks → action on the ground Ideas → real-world testing Parallel efforts → shared learning Join the FT3 Town Hall on May 13, 16:30 CET to to continue the conversation: precisionmedicine.synapseconnect.org/events/ft3-t...

precisionmedicine.synapseconnect.org

FT3 Town Hall Meeting May 2026

000

From Testing to Targeted Treatment (FT3) @ft3community.bsky.social · 04/05/2026

Ask a patient advocate, a payer, or a policy leader what’s wrong with HTA and you’ll hear different answers, all valid. Real progress begins when those perspectives come together. Join the ACCESS Series May 5 | 2:00–3:00 PM CEST precisionmedicine.synapseconnect.org/events/acces...

000

From Testing to Targeted Treatment (FT3) @ft3community.bsky.social · 01/05/2026

Join us for the ACCESS Series on May 5, 2:00–3:00 PM CEST on exploring how innovative health technologies can meet evolving HTA evidence needs. Speakers - Charles Alessi, Durhane Wong-Rieger, Daryl Pritchard, Cate Lockhart. Register here: precisionmedicine.synapseconnect.org/events/acces...

000

From Testing to Targeted Treatment (FT3) @ft3community.bsky.social · 30/04/2026

FT3 implementation is evolving through how systems learn and adapt. Patient-informed decisions, multidisciplinary care, and shared insights are driving early signals of connected precision medicine. Learn more from the January Town Hall: precisionmedicine.synapseconnect.org/resources/th...?

precisionmedicine.synapseconnect.org

The FT3 Community Is Moving Into Its Next Phase

000

From Testing to Targeted Treatment (FT3) @ft3community.bsky.social · 16/04/2026

In Mexico, stakeholders came together to explore how biomarker-guided care works in practice - from testing pathways to decision alignment. This is how implementation takes shape in real systems. Explore more from the January Town Hall: precisionmedicine.synapseconnect.org/resources/th...?

000

From Testing to Targeted Treatment (FT3) @ft3community.bsky.social · 09/04/2026

Access to precision medicine starts with informed dialogue and system readiness. Voices like Francisco’s show how local leadership is turning this into action, so patients benefit where it matters. Explore more: precisionmedicine.synapseconnect.org/resources/th...

000

From Testing to Targeted Treatment (FT3) @ft3community.bsky.social · 07/04/2026

Science only matters when it reaches people. This World Health Day, “Stand with Science” means turning breakthroughs into real-world care. From Nigeria to Mexico to Romania, collaboration is helping precision medicine move from discovery to delivery. #WorldHealthDay #StandWithScience

000

From Testing to Targeted Treatment (FT3) @ft3community.bsky.social · 31/03/2026

Navigating advanced colorectal cancer involves more than clinical decisions. This guide provides practical support for managing daily life and care conversations. precisionmedicine.synapseconnect.org/resources/li... #ColorectalCancerAwarenessMonth

100

From Testing to Targeted Treatment (FT3) @ft3community.bsky.social · 30/03/2026

Across the FT3 community, trust and shared ownership are turning alignment into action. This is how coordinated progress takes shape across systems. Explore the January Town Hall recap: tinyurl.com/5fd8yft6

000

From Testing to Targeted Treatment (FT3) @ft3community.bsky.social · 26/03/2026

From the FT3 January Town Hall to today, alignment is turning into action. Brazil is embedding patient voices in decisions. Mexico is advancing biomarker-driven care. Across countries, implementation is taking shape so patients benefit where it matters. Explore the full recap: tinyurl.com/47vewxsm

000

From Testing to Targeted Treatment (FT3) @ft3community.bsky.social · 24/03/2026

Colorectal cancer is a global challenge but care & outcomes vary widely across regions. The Global Colorectal Cancer Card offers a snapshot of key trends and gaps worldwide. precisionmedicine.synapseconnect.org/resources/gl... #ColorectalCancerAwarenessMonth

000

From Testing to Targeted Treatment (FT3) @ft3community.bsky.social · 17/03/2026

#ColorectalCancerAwarenessMonth is a reminder that the right information can help patients navigate care with greater confidence. The Colorectal Cancer & You Guidebook offers clear guidance on diagnosis, treatment options & questions to ask your care team. tinyurl.com/3h3cnk4p

000

From Testing to Targeted Treatment (FT3) @ft3community.bsky.social · 25/02/2026

Stakeholder misalignment remains one of the most persistent barriers in precision medicine. The Stakeholder Expectations Matrix, developed through FT3’s intelligence-gathering work, helps address these by mapping expectations across stakeholders. tinyurl.com/mva7cdbr

020

From Testing to Targeted Treatment (FT3) @ft3community.bsky.social · 24/02/2026

Earlier this year, Helena Harnik, Executive Director, FT3, shared a reflection on what we keep seeing across people-centred precision medicine systems. Now, a few weeks into 2026, the same structural patterns are continuing to surface, across countries and care settings: tinyurl.com/yrzsxfhs

000

From Testing to Targeted Treatment (FT3) @ft3community.bsky.social · 23/02/2026

At our January FT3 Townhall, we explored how precision medicine resources drive real impact only when they are culturally contextualised. These insights are now being strengthened through our Nigeria and Canada pilots and shaped by feedback from 116+ patients.

000

From Testing to Targeted Treatment (FT3) @ft3community.bsky.social · 20/02/2026

Earlier diagnosis plays a defining role in rare disease pathways, especially for medical affairs & PE professionals working to improve coordinated care. Join our session to explore patient-informed solutions. Register: precisionmedicine.synapseconnect.org/events/peof-...

000

From Testing to Targeted Treatment (FT3) @ft3community.bsky.social · 19/02/2026

For the medical community, rare diseases often challenge conventional diagnostic pathways. Here's a session exploring multidisciplinary diagnosis & pattern recognition. precisionmedicine.synapseconnect.org/events/peof-...

000

From Testing to Targeted Treatment (FT3) @ft3community.bsky.social · 18/02/2026

PEOF+ convenes rare disease patient communities for a focused discussion on earlier recognition, shared decision-making and navigating diagnostic journeys. Join Living with the Unknown on 27 February. precisionmedicine.synapseconnect.org/events/peof-...

000

From Testing to Targeted Treatment (FT3) @ft3community.bsky.social · 06/02/2026

Thanks to everyone who joined FT3’s recent Town Hall. A key takeaway: advocacy works best when it enables informed, constructive dialogue. FT3 is applying this in Mexico (with FUTEJE) and Nigeria (with Project Pink Blue).

000

From Testing to Targeted Treatment (FT3) @ft3community.bsky.social · 02/02/2026

In the lead-up to World Cancer Day 2026, FT3 Board Member Ivica Belina will chair an online CCI4EU roundtable on improving patient access to cancer research and clinical trials across Europe. Register here: events.teams.microsoft.com/event/93869c...

000

From Testing to Targeted Treatment (FT3) @ft3community.bsky.social · 20/01/2026

Precision medicine enters 2026 with momentum & real questions - How do we turn pilots into practice, align across sectors & scale what works? Join the conversation at FT3 Town Hall on Jan 22. precisionmedicine.synapseconnect.org/events/ft3-t... @nbrooke12.bsky.social

000

From Testing to Targeted Treatment (FT3) @ft3community.bsky.social · 19/01/2026

We’re pleased to welcome Espen Walker as a new Board Member at FT3. Espen is Head of Global Medical Diagnostics at AstraZeneca and a global leader in precision medicine, spanning diagnostics-led therapy, biomarker strategy, and digital solutions for personalised care.

010

From Testing to Targeted Treatment (FT3) @ft3community.bsky.social · 16/01/2026

Precision medicine is advancing, but implementation is the real test. Join the FT3 Town Hall on Jan 22 to explore how collaboration can turn local progress into lasting impact. precisionmedicine.synapseconnect.org/events/ft3-t... @nbrooke12.bsky.social

011